Stay updated on Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Sign up to get notified when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.

Latest updates to the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page
- Check2 days agoChange DetectedThe clinical trial record for a phase 2 study of jaktinib for idiopathic pulmonary fibrosis is displayed instead of an error page. It includes participant eligibility, treatment arms, outcome measures, and study dates.SummaryDifference46%

- Check9 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check16 days agoChange DetectedA sitewide banner announces updates about the NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check23 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer’s displayed ClinicalTrials.gov revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record, signaling an access issue or site block; the surrounding site chrome remains, but the main content is replaced.SummaryDifference18%

Stay in the know with updates to Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.